Evidence map›Paper›PMID 36792620›Full record

Trial reportScientific reports2023

Four-year follow-up on fatigue and sleep quality of a three-armed partly randomized controlled study in breast cancer survivors with cancer-related fatigue.

M Kröz, F Quittel, M Reif, R Zerm, D Pranga, C Bartsch, B Brinkhaus, A Büssing, C Gutenbrunner, CRF study group

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

M Kröz *Research Institute Havelhöhe (FIH), Kladower Damm 221, 14089, Berlin, Germany. Matthias.Kroez@havelhoehe.de.
F Quittel *Research Institute Havelhöhe (FIH), Kladower Damm 221, 14089, Berlin, Germany.
M ReifSociety for Clinical Research, Berlin, Germany.
R ZermResearch Institute Havelhöhe (FIH), Kladower Damm 221, 14089, Berlin, Germany.
D PrangaResearch Institute Havelhöhe (FIH), Kladower Damm 221, 14089, Berlin, Germany.
C BartschCenter for Research in Medical and Natural Sciences, University of Tübingen, Tübingen, Germany.
B BrinkhausCharité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute for Social Medicine, Epidemiology and Health Economics, Berlin, Germany.
A BüssingInstitute for Integrative Medicine, University of Witten/Herdecke, Witten, Herdecke, Germany.
C GutenbrunnerClinic for Rehabilitative Medicine, Hannover Medical School, Hannover, Germany.
CRF study group
Witten/Herdecke University · DEForschungsinstitut Havelhöhe · DEMedizinische Hochschule Hannover · DEDeleted InstitutionHumboldt-Universität zu Berlin · DEUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer-related fatigue (CRF) is a frequent long-term symptom in non-metastasized breast cancer patients (BC). This 4-year follow-up intended to compare the long-term effects of a 10-week multimodal therapy (MT: sleep education, psychoeducation, eurythmy- and painting therapy) and combination therapy [CT: MT plus aerobic training (AT)] to AT-control. BC-patients were randomized or allocated by preference to three arms in a comprehensive cohort study. Primary outcome was a composite score including Pittsburgh Sleep Quality Index (PSQI) and Cancer Fatigue Scale (CFS-D), captured at baseline, after 10 weeks of intervention (T1), 6 months later (T2), and after 4 years (T3). We exploratively tested for superiority of MT and CT versus AT after 4 years (T3) based on the statistical model of the main analysis. Of 126 (65 randomized) BC-patients included, 105 started treatments and 79 were re-assessed for long-term effects (T3). MT and CT were superior over AT after 4 years regarding PSQI/CFS-D and PSQI sum-score, respectively (all p < 0.05), but not for CFS-D. The multimodal and combination treatment for breast cancer patients with CRF indicates sustainable long-term superiority over aerobic training for the outcomes sleep quality and combined sleep quality/fatigue. A confirmative randomized controlled trial is warranted.

Indexed as

Breast NeoplasmsCancer SurvivorsCohort StudiesExercise TherapyFatigueFemaleFollow-Up StudiesHumansQuality of LifeSleepSleep Quality

Identifiers

PMID36792620
PMCPMC9931714
OpenAlexW4321003921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.